神経毒の世界市場レポート 2025年

神経毒の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.4％で124億7,000万米ドルに成長します。予測期間の成長は、神経学における用途の拡大、美容施術の継続的需要、製剤の技術革新、消費者意識の高まり、コスメティック・ツーリズムの拡大に起因しています。予測期間中の主な動向としては、ドラッグデリバリー技術の進歩、神経毒の開発と研究のための共同研究、神経毒業界における規制変更への市場対応、マルチモーダル治療計画における神経毒の統合、長時間持続する効果への注目、患者の満足度などが挙げられます。

神経毒市場の予想される成長は、見た目の改善を目的とした美容施術の急増によって促進されると予想されます。美容整形は、個人の身体的外観を向上または変更することを主な目的として実施される多様な医療介入を包含します。この動向は、社会的、技術的、文化的要因に加え、美容整形に関連する利点に対する意識の高まりに影響されています。神経毒は、特定の筋肉を弛緩させることにより、しわや小じわを目立たなくさせるという重要な役割を果たしています。例えば、2022年8月に米国形成外科学会が行った美容整形に関する調査では、美容整形に対する需要が大幅に増加していることが明らかになり、米国では形成外科医の4人に3人が需要の増加を指摘し、30％が美容整形事業の倍増を報告しています。外見を美しくするためのこのような美容施術の急増は、神経毒市場の成長を促進する主な要因です。

高齢化人口の増加は、今後の神経毒市場の成長を促進すると予想されます。高齢化」とは、社会や人口における高齢者の割合が増加することを特徴とする人口動態を指します。この高齢化層は、しわや表情じわのような加齢に関連した美容上の悩みに対処するために、ボトックスのような神経毒に基づく治療を求めることが多く、外見を向上させ、より若々しく若返った外見を促進する非侵襲的なソリューションを好みます。例えば、2024年1月、ケニアに本部を置く非営利団体、人口問題研究所は、65歳以上のアメリカ人の人口が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しました。同期間中、この年齢層が全人口に占める割合は17％から23％に増加すると予想されています。したがって、高齢化人口の増加が神経毒市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の神経毒PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の神経毒市場：成長率分析
• 世界の神経毒市場の実績：規模と成長, 2019-2024
• 世界の神経毒市場の予測：規模と成長, 2024-2029, 2034F
• 世界の神経毒総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の神経毒市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボトックス
• ディスポート
• ゼオミン
• その他の製品
• 世界の神経毒市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療
• 美容
• 世界の神経毒市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 皮膚科クリニック
• その他のエンドユーザー
• 世界の神経毒市場、タイプ別サブセグメンテーション：ボトックス、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化粧品での使用
• 治療での使用
• 世界の神経毒市場、タイプ別サブセグメンテーション：ディスポート、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化粧品用途
• 医学用途
• 世界の神経毒市場、タイプ別サブセグメンテーション：ゼオミン、実績と予測, 2019-2024, 2024-2029F, 2034F
• 美容治療
• 治療用途
• 世界の神経毒市場、タイプ別サブセグメンテーション：その他の製品、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジュヴォー
• 新規神経毒

第7章 地域別・国別分析

• 世界の神経毒市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の神経毒市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 神経毒市場：競合情勢
• 神経毒市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merz Pharma GmbH & Co KGaA
• Hugel Inc.
• Evolus Inc.
• Medytox Inc.
• Croma-Pharma GmbH
• Revance Therapeutics Inc.
• US WorldMeds
• Gufic Biosciences Ltd.
• Hironic Co. Ltd.
• Allergan
• List Biological Laboratories
• Lanzhou Institute of Biological Products Co. Ltd.
• Sinclair Pharma
• Vida Aesthetics
• Aquavit Holdings LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 神経毒市場2029：新たな機会を提供する国
• 神経毒市場2029：新たな機会を提供するセグメント
• 神経毒市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A neurotoxin is a substance that is specifically harmful to nerve cells (neurons) or the nervous system. These toxins function by inhibiting cellular processes within neurons. Neurotoxins are used to temporarily diminish wrinkles by paralyzing certain muscles and to treat conditions such as muscle spasticity, migraines, and excessive sweating. Additionally, they are utilized in research to explore nerve function and the mechanisms of neuronal signaling, contributing to the understanding of neurological disorders.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown rapidly in recent years. It will grow from $7.35 billion in 2024 to $8.09 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to a rise in aesthetic procedures, therapeutic applications, advancements in the cosmetic industry, a growing aging population, and increasing acceptance of non-surgical procedures

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $12.47 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to expanding applications in neurology, continued demand for aesthetic procedures, innovation in formulations, rising consumer awareness, and expansion of cosmetic tourism. Major trends in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market response to regulatory changes in the neurotoxin industry, integration of neurotoxins in multimodal treatment plans, focus on long-lasting effects, and patient satisfaction.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The increasing aging population is anticipated to drive the growth of the neurotoxin market in the future. The term "aging population" refers to a demographic trend marked by a rising proportion of elderly individuals within a society or population. This aging demographic often seeks neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns like wrinkles and facial lines, favoring non-invasive solutions that enhance their appearance and promote a more youthful, rejuvenated look. For example, in January 2024, the Population Reference Bureau, a Kenya-based nonprofit organization, projected that the population of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. During the same period, this age group's share of the overall population is expected to grow from 17% to 23%. Therefore, the growing aging population is driving the expansion of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In July 2023, Priveterra Acquisition Corp., a US-based special purpose acquisition company, acquired AEON Biopharma, Inc. for an undisclosed amount. This acquisition aims to create a publicly traded entity focused on advancing AEON's proprietary neurotoxin, ABP-450, which is designed to treat severe conditions such as chronic migraines. The deal intends to utilize up to $125 million in secured funding to support AEON's clinical development and commercialization efforts, thereby strengthening its position in the biopharmaceutical industry and driving growth in the neurosciences market. AEON Biopharma, Inc. is a US-based biopharmaceutical company that produces neurotoxins.

Major companies operating in the neurotoxin market include AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd, Entod Pharmaceuticals, Object Pharma Inc.

North America was the largest region in the neurotoxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Botox; Dysport; Xeomin; Other Products
• 2) By Application: Therapeutic; Aesthetic
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Botox: Cosmetic Uses; Therapeutic Uses
• 2) By Dysport: Cosmetic Applications; Medical Indications
• 3) By Xeomin: Cosmetic Treatments; Therapeutic Applications
• 4) By Other Products: Jeuveau; Any Emerging Neurotoxins
• Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Neurotoxin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Neurotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Neurotoxin Market Growth Rate Analysis
• 5.4. Global Neurotoxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Neurotoxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Neurotoxin Total Addressable Market (TAM)

6. Neurotoxin Market Segmentation

• 6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botox
• Dysport
• Xeomin
• Other Products
• 6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic
• Aesthetic
• 6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users
• 6.4. Global Neurotoxin Market, Sub-Segmentation Of Botox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Uses
• Therapeutic Uses
• 6.5. Global Neurotoxin Market, Sub-Segmentation Of Dysport, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Applications
• Medical Indications
• 6.6. Global Neurotoxin Market, Sub-Segmentation Of Xeomin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmetic Treatments
• Therapeutic Applications
• 6.7. Global Neurotoxin Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Jeuveau
• Any Emerging Neurotoxins

7. Neurotoxin Market Regional And Country Analysis

• 7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurotoxin Market

• 8.1. Asia-Pacific Neurotoxin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurotoxin Market

• 9.1. China Neurotoxin Market Overview
• 9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurotoxin Market

• 10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurotoxin Market

• 11.1. Japan Neurotoxin Market Overview
• 11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurotoxin Market

• 12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurotoxin Market

• 13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurotoxin Market

• 14.1. South Korea Neurotoxin Market Overview
• 14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurotoxin Market

• 15.1. Western Europe Neurotoxin Market Overview
• 15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurotoxin Market

• 16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurotoxin Market

• 17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurotoxin Market

• 18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurotoxin Market

• 19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurotoxin Market

• 20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurotoxin Market

• 21.1. Eastern Europe Neurotoxin Market Overview
• 21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurotoxin Market

• 22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurotoxin Market

• 23.1. North America Neurotoxin Market Overview
• 23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurotoxin Market

• 24.1. USA Neurotoxin Market Overview
• 24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurotoxin Market

• 25.1. Canada Neurotoxin Market Overview
• 25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurotoxin Market

• 26.1. South America Neurotoxin Market Overview
• 26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurotoxin Market

• 27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurotoxin Market

• 28.1. Middle East Neurotoxin Market Overview
• 28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurotoxin Market

• 29.1. Africa Neurotoxin Market Overview
• 29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

• 30.1. Neurotoxin Market Competitive Landscape
• 30.2. Neurotoxin Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Galderma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ipsen SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Daewoong Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Supernus Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Neurotoxin Market Other Major And Innovative Companies

• 31.1. Merz Pharma GmbH & Co KGaA
• 31.2. Hugel Inc.
• 31.3. Evolus Inc.
• 31.4. Medytox Inc.
• 31.5. Croma-Pharma GmbH
• 31.6. Revance Therapeutics Inc.
• 31.7. US WorldMeds
• 31.8. Gufic Biosciences Ltd.
• 31.9. Hironic Co. Ltd.
• 31.10. Allergan
• 31.11. List Biological Laboratories
• 31.12. Lanzhou Institute of Biological Products Co. Ltd.
• 31.13. Sinclair Pharma
• 31.14. Vida Aesthetics
• 31.15. Aquavit Holdings LLC

32. Global Neurotoxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurotoxin Market

34. Recent Developments In The Neurotoxin Market

35. Neurotoxin Market High Potential Countries, Segments and Strategies

• 35.1 Neurotoxin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Neurotoxin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Neurotoxin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer